Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir-Reference-Cited by-同舟云学术

Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir

Published:2013-11-11 Issue:1 Volume:59 Page:46-48
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Mauss Stefan¹,Hueppe Dietrich²,Alshuth Ulrich³

Affiliation:

1. Center for HIV and Hepatogastroenterology; Duesseldorf Germany

2. Center for Gastroenterology; Herne Germany

3. BU Virology, Roche Pharma AG; Grenzach-Wyhlen Germany

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.26602/fullpdf

Reference6 articles.

1. Telaprevir for previously untreated chronic hepatitis C virus infection;Jacobson;N Engl J Med,2011

2. Telaprevir for previously treated chronic HCV infection;McHutchison;N Engl J Med,2010

3. Boceprevir for untreated chronic HCV genotype 1 infection;Poordad;N Engl J Med,2011

4. Boceprevir with peginterferon alfa-2a-ribavirin is effective for previously treated chronic hepatitis C genotype 1 infection;Flamm;Clin Gastroenterol Hepatol,2013

5. Safety and efficacy of telaprevir or boceprevir in combination with peginterferon alfa/ribavirin, in 497 cirrhotic non responders. Week 16 analysis of the French early access program (ANRS CO20-CUPIC) in real-life setting;Hézode;Hepatology,2012

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Sofosbuvir/Ledipasvir and Glecaprevir/Pibrentasvir on Serum Creatinine;Journal of Clinical and Experimental Hepatology;2021-08

2. Blood Glucose and Renal Function Evaluation in Patients with Viral Hepatitis;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2021-07

3. High S100A2 expression in keratinocytes in patients with drug eruption;Scientific Reports;2021-03-09

4. Liver Disease and Chronic Kidney Disease;Chronic Renal Disease;2020

5. Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation;Hemodialysis International;2018-04